The Role of the Inflammasome in Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are chronic, progressive disorders that occur in the central nervous system (CNS). They are characterized by the loss of neuronal structure and function and are associated with inflammation. Inflammation of the CNS is called neuroinflammation, which has been implicated in most neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). Much evidence indicates that these different conditions share a common inflammatory mechanism: the activation of the inflammasome complex in peripheral monocytes and in microglia, with the consequent production of high quantities of the pro-inflammatory cytokines IL-1β and IL-18. Inflammasomes are a group of multimeric signaling complexes that include a sensor Nod-like receptor (NLR) molecule, the adaptor protein ASC, and caspase-1. The NLRP3 inflammasome is currently the best-characterized inflammasome. Multiple signals, which are potentially provided in combination and include endogenous danger signals and pathogens, trigger the formation of an active inflammasome, which, in turn, will stimulate the cleavage and the release of bioactive cytokines including IL-1β and IL-18. In this review, we will summarize results implicating the inflammasome as a pivotal player in the pathogenesis of neurodegenerative diseases and discuss how compounds that hamper the activation of the NLRP3 inflammasome could offer novel therapeutic avenues for these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, caspase-1 also induces pyroptosis, which is characterized by gasdermin D (GSDMD) mediated plasma membrane rupture.347”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [347]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Mechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,503
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Inflammasomes and Their Roles in Health and Disease
Lamkanfi, M., & Dixit, V. M. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155745 · Cited by 935
Role of neuroinflammation in neurodegenerative diseases (Review)
CHEN, W.-W., ZHANG, X., & HUANG, W.-J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4948 · Cited by 932
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Gordon, R., Albornoz, E. A., Christie, D. C., Langley, M. R., Kumar, V., Mantovani, S., Robertson, A. A. B., Butler, M. S., Rowe, D. B., O’Neill, L. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4066 · Cited by 897
Repression of α-synuclein expression and toxicity by microRNA-7
Junn, E., Lee, K.-W., Jeong, B. S., Chan, T. W., Im, J.-Y., & Mouradian, M. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906277106 · Cited by 655
Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
Juliana, C., Fernandes-Alnemri, T., Wu, J., Datta, P., Solorzano, L., Yu, J.-W., Meng, R., Quong, A. A., Latz, E., Scott, C. P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082305 · Cited by 610
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies
Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585
Dempsey, C., Rubio Araiz, A., Bryson, K. J., Finucane, O., Larkin, C., Mills, E. L., Robertson, A. A. B., Cooper, M. A., O'Neill, L. A. J., & Lynch, M. A. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.12.014 · Cited by 571
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
Saresella, M., La Rosa, F., Piancone, F., Zoppis, M., Marventano, I., Calabrese, E., Rainone, V., Nemni, R., Mancuso, R., & Clerici, M. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0088-1 · Cited by 489
Self-citationThe microglial "activation" continuum: from innate to adaptive responses
Town, T., Nikolic, V., & Tan, J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-24 · Cited by 456
Zhou, Y., Lu, M., Du, R.-H., Qiao, C., Jiang, C.-Y., Zhang, K.-Z., Ding, J.-H., & Hu, G. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0094-3 · Cited by 455
Daniels, M. J. D., Rivers-Auty, J., Schilling, T., Spencer, N. G., Watremez, W., Fasolino, V., Booth, S. J., White, C. S., Baldwin, A. G., Freeman, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12504 · Cited by 442
Lee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431
Gris, D., Ye, Z., Iocca, H. A., Wen, H., Craven, R. R., Gris, P., Huang, M., Schneider, M., Miller, S. D., & Ting, J. P.-Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904145 · Cited by 429
Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology
Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C. A., Tan, J., Duman, R. S., & Flavell, R. A. (2008) · Nature Medicine · doi:10.1038/nm1781 · Cited by 422
Hawkes, C. A., & McLaurin, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805453106 · Cited by 397
Animal models of multiple sclerosis: the good, the bad and the bottom line
Ransohoff, R. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3168 · Cited by 379
Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer’s disease
Tan, M.-S., Tan, L., Jiang, T., Zhu, X.-C., Wang, H.-F., Jia, C.-D., & Yu, J.-T. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.348 · Cited by 347
Ineffective phagocytosis of amyloid-β by macrophages of Alzheimer's disease patients
Fiala, M., Lin, J., Ringman, J., Kermani-Arab, V., Tsao, G., Patel, A., Lossinsky, A. S., Graves, M. C., Gustavson, A., Sayre, J., et al. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7304 · Cited by 330
Inflammasome-independent regulation of IL-1-family cytokines
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W. M., Dinarello, C. A., & Joosten, L. A. B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112306 · Cited by 326
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Meissner, F., Molawi, K., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002396107 · Cited by 318
Neuroinflammation in Neurodegenerative Disorders-a Review
Schain, M., & Kreisl, W. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0733-2 · Cited by 301
Alboni, S., Cervia, D., Sugama, S., & Conti, B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-9 · Cited by 299
Kaushal, V, Dye, R., Pakavathkumar, P., Foveau, B., Flores, J., Hyman, B., Ghetti, B., Koller, B. H., & LeBlanc, A. C. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.16 · Cited by 297
Johann, S., Heitzer, M., Kanagaratnam, M., Goswami, A., Rizo, T., Weis, J., Troost, D., & Beyer, C. (2015) · Glia · doi:10.1002/glia.22891 · Cited by 277
The NLRP3 Inflammasome in Alzheimer’s Disease
Tan, M.-S., Yu, J.-T., Jiang, T., Zhu, X.-C., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8475-x · Cited by 248
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome
Zhao, W., Beers, D. R., Bell, S., Wang, J., Wen, S., Baloh, R. H., & Appel, S. H. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.019 · Cited by 241
The Role of Immune and Inflammatory Mechanisms in ALS
A. McCombe, P., & D. Henderson, R. (2011) · Current Molecular Medicine · doi:10.2174/156652411795243450 · Cited by 232
Parajuli, B., Sonobe, Y., Horiuchi, H., Takeuchi, H., Mizuno, T., & Suzumura, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.503 · Cited by 232
Fan, Z., Pan, Y.-T., Zhang, Z.-Y., Yang, H., Yu, S.-Y., Zheng, Y., Ma, J.-H., & Wang, X.-M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1670-6 · Cited by 228
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
Fowler, B. J., Gelfand, B. D., Kim, Y., Kerur, N., Tarallo, V., Hirano, Y., Amarnath, S., Fowler, D. H., Radwan, M., Young, M. T., et al. (2014) · Science · doi:10.1126/science.1261754 · Cited by 225
Post-translational regulation of inflammasomes
Yang, J., Liu, Z., & Xiao, T. S. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.29 · Cited by 202
Inoue, M., Williams, K. L., Oliver, T., Vandenabeele, P., Rajan, J. V., Miao, E. A., & Shinohara, M. L. (2012) · Science Signaling · doi:10.1126/scisignal.2002767 · Cited by 194
Nascimento, C., Pereira, J., Andrade, L., Garuffi, M., Talib, L., Forlenza, O., Cancela, J., Cominetti, M., & Stella, F. (2014) · Current Alzheimer Research · doi:10.2174/156720501108140910122849 · Cited by 192
Awad, F., Assrawi, E., Jumeau, C., Georgin-Lavialle, S., Cobret, L., Duquesnoy, P., Piterboth, W., Thomas, L., Stankovic-Stojanovic, K., Louvrier, C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175336 · Cited by 191
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Dionisio-Santos, D. A., Olschowka, J. A., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1453-0 · Cited by 184
α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
Harms, A. S., Delic, V., Thome, A. D., Bryant, N., Liu, Z., Chandra, S., Jurkuvenaite, A., & West, A. B. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0494-9 · Cited by 181
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
Mamik, M. K., & Power, C. (2017) · Brain · doi:10.1093/brain/awx133 · Cited by 161
Origins and Effects of Extracellular α-synuclein: Implications in Parkinson’s Disease
Lee, S.-J. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0012-9 · Cited by 159
Inflammasome activation and innate immunity in Alzheimer's disease
Heneka, M. T. (2017) · Brain Pathology · doi:10.1111/bpa.12483 · Cited by 156
T cell–intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis
Martin, B. N., Wang, C., Zhang, C.-J., Kang, Z., Gulen, M. F., Zepp, J. A., Zhao, J., Bian, G., Do, J.-S., Min, B., et al. (2016) · Nature Immunology · doi:10.1038/ni.3389 · Cited by 155
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Bayer, T. A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.007 · Cited by 140
de Jong, B. A., Huizinga, T. W. J., Bollen, E. L. E. M., Uitdehaag, B. M. J., Bosma, G. P. T., van Buchem, M. A., Remarque, E. J., Burgmans, A. C. S., Kalkers, N. F., Polman, C. H., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00056-5 · Cited by 136
Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
Béraud, D., & Maguire-Zeiss, K. A. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70008-6 · Cited by 134
Burger, D., Molnarfi, N., Weber, M. S., Brandt, K. J., Benkhoucha, M., Gruaz, L., Chofflon, M., Zamvil, S. S., & Lalive, P. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812183106 · Cited by 132
Simard, A. R., & Rivest, S. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001809 · Cited by 124
Inoue, M., & Shinohara, M. L. (2013) · Autoimmune Diseases · doi:10.1155/2013/859145 · Cited by 124
Inflammasome Proteins As Biomarkers of Multiple Sclerosis
Keane, R. W., Dietrich, W. D., & de Rivero Vaccari, J. P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00135 · Cited by 124
A Complex Proinflammatory Role for Peripheral Monocytes in Alzheimer's Disease
Saresella, M., Marventano, I., Calabrese, E., Piancone, F., Rainone, V., Gatti, A., Alberoni, M., Nemni, R., & Clerici, M. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-131160 · Cited by 121
Self-citationTownsend, K. P., Town, T., Mori, T., Lue, L., Shytle, D., Sanberg, P. R., Morgan, D., Fernandez, F., Flavell, R. A., & Tan, J. (2005) · European Journal of Immunology · doi:10.1002/eji.200425585 · Cited by 121
Shi, J., Zhang, C., Sun, X., Cheng, X., Wang, J., Zhang, Y., Xu, J., & Zou, H. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12066 · Cited by 115
Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients
Amorini, A. M., Petzold, A., Tavazzi, B., Eikelenboom, J. M., Keir, G., Belli, A., Giovannoni, G., Pietro, V. D., Polman, C. H., D’Urso, S., et al. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.03.020 · Cited by 114
Caspase-1 expression in multiple sclerosis plaques and cultured glial cells
Ming, X., Li, W., Maeda, Y., Blumberg, B. M., Raval, S., Cook, S. D., & Dowling, P. C. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00030-8 · Cited by 111
Increased serum levels of interleukin-18 in patients with multiple sclerosis
Nicoletti, F., Di Marco, R., Mangano, K., Patti, F., Reggio, E., Nicoletti, A., Bendtzen, K., & Reggio, A. (2001) · Neurology · doi:10.1212/wnl.57.2.342 · Cited by 110
Trumble, B. C., Stieglitz, J., Blackwell, A. D., Allayee, H., Beheim, B., Finch, C. E., Gurven, M., & Kaplan, H. (2017) · The FASEB Journal · doi:10.1096/fj.201601084r · Cited by 106
IL-18 in patients with multiple sclerosis: IL-18 in MS
Losy, J., & Niezgoda, A. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00356.x · Cited by 105
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
Italiani, P., Carlesi, C., Giungato, P., Puxeddu, I., Borroni, B., Bossù, P., Migliorini, P., Siciliano, G., & Boraschi, D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-94 · Cited by 103
Cdk5‐Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease
Zhang, P., Shao, X., Qi, G., Chen, Q., Bu, L., Chen, L., Shi, J., Ming, J., & Tian, B. (2016) · Movement Disorders · doi:10.1002/mds.26488 · Cited by 102
NALP1/NLRP1 Genetic Variants are Associated With Alzheimer Disease
Pontillo, A., Catamo, E., Arosio, B., Mari, D., & Crovella, S. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318231a8ac · Cited by 99
Dimethyl sulfoxide inhibits NLRP3 inflammasome activation
Ahn, H., Kim, J., Jeung, E., & Lee, G. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.11.003 · Cited by 91
Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice
Debye, B., Schmülling, L., Zhou, L., Rune, G., Beyer, C., & Johann, S. (2018) · Brain Pathology · doi:10.1111/bpa.12467 · Cited by 81
Gain-of-function of P2X7 receptor gene variants in multiple sclerosis
Oyanguren-Desez, O., Antigüedad, A. R., Villoslada, P., Domercq, M., Alberdi, E. M., & Matute, C. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.08.002 · Cited by 79
Nicoletti, F., Patti, F., Marco, R. D., Zaccone, P., Nicoletti, A. S. Q., Meroni, P. L., & Reggio, A. (1996) · Cytokine · doi:10.1006/cyto.1996.0054 · Cited by 76
Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis
Chen, Y.-C., Chen, S., Miao, L., Liu, Z., Li, W., Zhao, Z., Sun, X., Jiang, G., & Cheng, Q. H. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.12.008 · Cited by 73
Furlan, R., Filippi, M., Bergami, A., Rocca, M. A., Martinelli, V, Poliani, P. L., Grimaldi, L. M. E., Desina, G., Comi, G., & Martino, G. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.785 · Cited by 72
Peelen, E., Damoiseaux, J. G. M. C., Muris, A., Knippenberg, S. A. M., Smolders, J., Hupperts, R., & Thewissen, M. M. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.10.008 · Cited by 70
Serum uric acid levels in patients with multiple sclerosis: a meta-analysis
Liu, B., Shen, Y., Xiao, K., Tang, Y., Cen, L., & Wei, J. (2012) · Neurological Research · doi:10.1179/1743132811y.0000000074 · Cited by 69
Heitzer, M., Kaiser, S., Kanagaratnam, M., Zendedel, A., Hartmann, P., Beyer, C., & Johann, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0322-4 · Cited by 69
Neurodegenerative diseases as proteinopathies-driven immune disorders
Lanuti, P., Ciccocioppo, F., Bologna, G., Ercolino, E., Pierdomenico, L., Simeone, P., Pieragostino, D., Del Boccio, P., Marchisio, M., & Miscia, S. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.268971 · Cited by 69
CD40 signaling and Alzheimer's disease pathogenesis
Town, T., Tan, J., & MULLAN, M. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00044-4 · Cited by 65
Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
Liu, Z., Cheng, X., Zhong, S., Zhang, X., Liu, C., Liu, F., & Zhao, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00575 · Cited by 65
How to Get from Here to There: Macrophage Recruitment in Alzheimers Disease
Rezai-Zadeh, K., Gate, D., Gowing, G., & Town, T. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256017 · Cited by 64
Protein aggregation, misfolding and consequential human neurodegenerative diseases
Sami, N., Rahman, S., Kumar, V., Zaidi, S., Islam, A., Ali, S., Ahmad, F., & Hassan, M. I. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1286339 · Cited by 64
The Cyclopentenone Prostaglandin 15d-PGJ2 Inhibits the NLRP1 and NLRP3 Inflammasomes
Maier, N. K., Leppla, S. H., & Moayeri, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401611 · Cited by 63
Monocytes and Alzheimer’s disease
Feng, Y., Li, L., & Sun, X. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1205-3 · Cited by 62
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy
La Rosa, F., Saresella, M., Marventano, I., Piancone, F., Ripamonti, E., Al-Daghri, N., Bazzini, C., Zoia, C. P., Conti, E., Ferrarese, C., et al. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181259 · Cited by 59
Self-citationKadhim, H., Deltenre, P., Martin, J.-J., & Sébire, G. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2015.11.022 · Cited by 54
Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
Duan, Y., Kelley, N., & He, Y. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.272576 · Cited by 52
Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis
Piancone, F., Saresella, M., Marventano, I., Rosa, F. L., Santangelo, M. A., Caputo, D., Mendozzi, L., Rovaris, M., & Clerici, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00983 · Cited by 50
Self-citationPierini, R., Perret, M., Djebali, S., Juruj, C., Michallet, M., Förster, I., Marvel, J., Walzer, T., & Henry, T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203326 · Cited by 41
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis
Caragnano, M., Tortorella, P., Bergami, A., Ruggieri, M., Livrea, P., Specchio, L. M., Martino, G., Trojano, M., Furlan, R., & Avolio, C. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.002 · Cited by 32
Parkinson Disease Genetics: A “Continuum” from Mendelian to Multifactorial Inheritance
Petrucci, S., Consoli, F., & Valente, E. M. (2014) · Current Molecular Medicine · doi:10.2174/1566524014666141010155509 · Cited by 30
Interaction between glutamate signalling and immune attack in damaging oligodendrocytes
Matute, C. (2007) · Neuron Glia Biology · doi:10.1017/s1740925x08000033 · Cited by 26
Leishmania infantum infection reduces the amyloid β42-stimulated NLRP3 inflammasome activation
Saresella, M., Basilico, N., Marventano, I., Perego, F., Rosa, F. L., Piancone, F., Taramelli, D., Banks, H., & Clerici, M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.058 · Cited by 23
Self-citationAllan, S. M. (2004) · Humana Press eBooks · doi:10.1385/1-59259-836-6:333 · Cited by 13
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“Moreover, caspase-1 also induces pyroptosis, which is characterized by gasdermin D (GSDMD) mediated plasma membrane rupture.(347) Numerous inflammasomes have thus far been identified.”
BackgroundResultNeuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
Rauf, A., Badoni, H., Abu-Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P., & Mubarak, M. S. (2022) · Molecules · doi:10.3390/molecules27103194 · Cited by 306
“The inflammasome, nucleotidebinding oligomerization domain leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3), is the most intensively investigated inflammasome, which has been reported as a critical player in neurodegenerative diseases [10].”
BackgroundRetractedSalaudeen, M. A., Bello, N., Danraka, R. N., & Ammani, M. L. (2024) · Biomolecules · doi:10.3390/biom14030305 · Cited by 175
“…ischemia, the activation of inflammasomes leads to the activation of caspase-1, which cleaves pro-IL-1 β and IL-17 to produce IL-1 β and IL-17, respectively, both of which are key inflammatory cytokines, inducing neuronal death along with other pro-inflammatory factors during pyroptosis [44].”
BackgroundRoles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 143
Yang, K., Zeng, L., Yuan, X., Wang, S., Ge, A., Xu, H., Zeng, J., & Ge, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113611 · Cited by 104
Metadata
- Authors
- Piancone, F., La Rosa, F., Marventano, I., Saresella, M., & Clerici, M.
- Affiliations
- Don Carlo Gnocchi Foundation (IT)
- IRCCS Fondazione Don Carlo Gnocchi, 20148 Milano, Italy
- University of Milan (IT)
- Corresponding author
- Piancone, Federica
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-02-11
- Volume
- 26
- Issue
- 4
- Pages
- 953
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7916884
- OpenAlex
- W3128695211
- Cited by
- 144
- References
- 99
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 29 · 2023: 27 · 2022: 28 · 2021: 12
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- inflammasome, neurodegenerative diseases, neuroinflammation, NLRP3 inflammasome, IL-1β, IL-18, caspase-1, NOD-like receptors, microglia, monocytes, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, inflammasome inhibitors, neuroinflammation therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Humans, Multiple Sclerosis, Parkinson Disease, Signal Transduction, Neurodegenerative Diseases, Interleukin-18, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.